Recrutamento encerrado
FASE
Número Europeu 2019-001164-30
FOENIX-MBC2 TAS-120-201
A Phase 2 Study of TAS-120 in Metastatic Breast Cancers Harboring Fibroblast Growth Factor Receptor (FGFR) Amplifications
Detalhes
Destaques